Traumatic stress, biological aging, and heart/stroke risk in Veterans

Traumatic Stress, Epigenetic Aging, and Cardiovascular Risk in the Million Veteran Program

NIH-funded research VA Boston Health Care System · NIH-11043948

This project looks at whether past traumatic stress speeds up biological aging in DNA and raises the chance of heart disease and stroke for Veterans.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionVA Boston Health Care System NIH-funded
Lab location1 site (Boston, United States)
Project IDNIH-11043948 on NIH RePORTER

What this research studies

Researchers will analyze health records and DNA methylation data from about 45,600 Veterans enrolled in the Million Veteran Program to measure epigenetic (biological) age using clocks like Horvath and GrimAge. They will examine links between prior traumatic stress and faster epigenetic aging, and whether faster epigenetic age helps explain new cases of heart disease and stroke over time. The team will test how factors like diet, exercise, medications, and genetics change those links. Finally, they will build a risk algorithm using epigenetic age and genetic analyses to better predict cardiovascular risk related to trauma.

Who could benefit from this research

Good fit: U.S. Veterans who are enrolled in the Million Veteran Program with available DNA methylation data and health records—especially those with a history of traumatic stress—are the ideal participants for this work.

Not a fit: People who are not Veterans or are not enrolled in the Million Veteran Program, or those without DNA methylation data, are unlikely to directly participate or benefit from this project.

Why it matters

Potential benefit: If successful, this work could help identify Veterans whose past trauma has increased their biological age and cardiovascular risk, enabling earlier prevention or tailored care.

How similar studies have performed: Prior studies have linked traumatic stress and accelerated epigenetic aging to worse heart outcomes, but using a very large Veteran dataset and developing a predictive epigenetic risk algorithm is relatively new.

Where this research is happening

Boston, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.